tag institute-cancer-research 
pharmaphorum
DECEMBER 23, 2022
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. These are particularly important in the progression of certain blood cancers.
pharmaphorum
OCTOBER 4, 2022
In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot. Central to the initiative is the aim to gather data from willing participants that can provide greater insights into cancer development and treatment over time. Building a bank.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
NOVEMBER 10, 2022
Advanced light microscopy techniques have emerged as a foundation of biomedical research, capable of visualising cellular functions at very high resolution whilst being minimally invasive to the cells or tissues of interest. This will help researchers to understand how formulation can improve cellular uptake to be more efficient.
Evolve Your Success
JUNE 13, 2023
Kelly currently thrives in diagnostic testing sales, specifically in a department that deals with skin cancer prognosis. We’re looking at skin cancer like melanoma and squamous cell carcinoma. We provide a service for cancer patients. That’s a good thing that you don’t have any cancer patients that you’ve seen.
European Pharmaceutical Review
DECEMBER 27, 2023
production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic departments CAR T production slots are assigned based on availability and a periodic quota system per referring institution or geographic location. This is in addition to its considerable price tag. 2019;12(1).
Expert insights. Personalized for you.
52 
Let's personalize your content